Funding
← Back to your selection

European Investment Bank (EIB)

Activity from announced rounds

All recorded activity
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$58.6M
2 disclosed · full round size, not this investor’s share

By stage

Undisclosed2

By primary sector

Biotech1
Healthtech1

By country

Belgium1
Germany1

Rounds

2 in all activity
Ethris

Ethris develops inhaled mRNA therapeutics and vaccines for respiratory diseases, using proprietary RNA stabilization and nanoparticle delivery platforms.

€30MHERA Invest financing
Participant